x

Like our Facebook Page

   
Early Times Newspaper Jammu, Leading Newspaper Jammu
 
Breaking News :   New changes worth learning between the two moons and earth | Nature-Based Solutions for the Air Pollution Crisis: A Green Path to Cleaner Cities | ‘Vande Mataram’ | Commitment, dedication will make ‘Bharat Viksit’: LG Sinha | BJP brings in Jugal Kishore to pacify ‘annoyed’ workers | Judicial panel invites public testimonies in Leh clash probe | Doctor from Kashmir arrested in UP for posting JeM posters | Didn’t authorise celebration of 150th anniversary of ‘Vande Mataram’ in schools: CM Omar | EOW chargesheets 4 Revenue officials | 150 years on, ‘Vande Mataram’ continues to ignite eternal flame of Nationalism: Amit Shah | Srinagar Court convicts Police Sub-Inspector for forging DOB | Date of regularization, not ad hoc entry, decisive for pension: HC | HC upholds detention of woman OGW | Seniority can’t be re-fixed through contempt petitions: DB | Maternity leave is a right: CAT | Back Issues  
 
news details
India to face COVID-19 vaccine shortage till July, says SII chief Adar Poonawalla
5/3/2021 1:01:48 PM
Agencies
New Delhi: Amid surge in COVID-19 infections in the country, Serum Institute of India (SII) chief Adar Poonawalla revealed that the issue of vaccine shortage in India will last for months.

India is currently battling the second wave of deadly coronavirus. With over 3 lakh cases and record deaths, India’s current pandemic situation is the worst around the globe.

Amid the rising questions surrounding the supply of COVID-19 vaccine, Serum Institute of India (SII) chief Adar Poonawalla said that the production of COVID-19 vaccines is expected to increase in July.

As per a report in the Financial Times, SII chief revealed that in July this year, the production capacity of COVID-19 vaccine will increase from 70 million doses a month to about 100 million doses a month.

SII chief’s statement comes a couple of days after the country commenced its third vaccination drive on May 1, in which all those above the age of 18 years are eligible to receive COVID-19 vaccine dose.

While speaking on the situation in India, Adar Poonawalla also highlighted that the authorities did not expect the second wave of COVID-19 to be this deadly and this soon. Everybody really felt that India had started to turn the tide on the pandemic," Poonawalla was quoted a saying.

Adding that if the authorities would have directed his firm to increase production as a caution back in time, they would have happily complied. "There were no orders, we did not think we needed to make more than 1 billion doses a year," Adar Poonawalla said.

Currently, Serum Institute of India (SII) is producing the COVID-19 vaccine developed by AstraZeneca and Oxford University in the UK.

Meanwhile, India reported a spike of 3,68,147 fresh coronavirus infections, taking the cumulative caseload to 1,99,25,604 on Monday (May 3, 2021), as per data by the health ministry.

The country's total COVID-19 caseload has now increased to 1.99 crore (1,99,25,604), of which, 34.13 lakh (34,13,642) are active cases. India has also witnessed 3,417 deaths in the last 24 hours, taking the toll to 2.18 lakh (2,18,959) coronavirus-related deaths
  Share This News with Your Friends on Social Network  
  Comment on this Story  
 
 
 
Early Times Android App
STOCK UPDATE
 
 
 
 
 
 
 
   
Home About Us Top Stories Local News National News Sports News Opinion Editorial ET Cetra Advertise with Us ET E-paper
 
 
J&K RELATED WEBSITES
J&K Govt. Official website
Jammu Kashmir Tourism
JKTDC
Mata Vaishnodevi Shrine Board
Shri Amarnath Ji Shrine Board
Shri Shiv Khori Shrine Board
UTILITY
Train Enquiry
IRCTC
Matavaishnodevi
BSNL
Jammu Kashmir Bank
State Bank of India
PUBLIC INTEREST
Passport Department
Income Tax Department
JK CAMPA
JK GAD
IT Education
Web Site Design Services
EDUCATION
Jammu University
Jammu University Results
JKBOSE
Kashmir University
IGNOU Jammu Center
SMVDU